Sign Up
Stories
DeepMirror Launches AI-Powered Drug Design Software
Share
ADvantage Therapeutics Appoints Professo...
AI Advancements in Drug Discovery
AI-Driven Discovery and Insurance Innova...
AI Enhances Animal Behavior Studies
AI Partnerships Drive Drug Discovery
AI Revolutionizes Healthcare Diagnosis
Overview
API
DeepMirror, a University of Cambridge spin-out, has introduced a new software program aimed at accelerating drug discovery through AI-powered molecular design. The software simplifies the design process and predicts properties such as drug binding, bio-activity, and toxicity.
Ask a question
How might the widespread adoption of DeepMirror's AI-powered drug design software impact the pharmaceutical industry?
In what ways could the introduction of AI-driven drug design software influence the future of medicine?
What are the potential ethical considerations and regulatory challenges associated with the use of AI in drug discovery?
Article Frequency
0.2
0.4
0.6
0.8
1.0
Sep 2023
Oct 2023
Nov 2023
Coverage